{"layout":"Indikator","sdg_goal":"3","goal_number":"3","indicator_number":"3.d.2","indicator_sort_order":"03-dd-02","permalink":"/3-d-2/","reporting_status":"complete","published":true,"data_non_statistical":false,"national_indicator_available":"Anteil der Blutvergiftungen, die von bestimmten gegen antimikrobielle Wirkstoffe resistenten Organismen verursacht werden","comparison_sdg":null,"goal_meta_national_link":null,"goal_meta_national_link_text":"Metadaten zu den dargestellten Zeitreihen","indicator_name":"Anteil der Blutvergiftungen, die von bestimmten gegen antimikrobielle Wirkstoffe resistenten Organismen verursacht werden","target_name":"Die Kapazit\u00e4ten aller L\u00e4nder, insbesondere der Entwicklungsl\u00e4nder, in den Bereichen Fr\u00fchwarnung, Risikominderung und Management nationaler und globaler Gesundheitsrisiken st\u00e4rken","target_id":"3.d","un_designated_tier":"<a href='https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/' title='Klicken Sie hier um weitere Informationen zur UN-Tier-Klassifikation zu erhalten.'  target='_blank'>Tier II</a>","un_custodian_agency":null,"goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf","goal_meta_link_text":"Metadaten zu diesem Indikator","source_active_1":true,"source_organisation_1":"Robert Koch-Institut (RKI)","source_organisation_logo_1":"<a href=\"https://www.rki.de/DE/Home/homepage_node.html\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgDe/rki.png\" alt=\"Logo rki\" style=\"height:60px; width:148px\"/></a>","source_url_1":"https://apps.who.int/gho/tableau-public/tpc-frame.jsp?id=2012","source_url_text_1":"WHO - GLASS L\u00e4nderprofile, 2018 (nur auf Englisch verf\u00fcgbar)","source_url_1b":"https://www.ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/data-ecdc","source_url_text_1b":"Daten aus dem ECDC Surveillance Atlas - Antimikrobielle Resistenz (nur auf Englisch verf\u00fcgbar)","source_active_2":false,"source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"data_keywords":null,"data_show_map":false,"data_start_values":[{"field":"Antimikrobiell-resistente Organismen","value":"Escherichia coli mit Resistenz gegen\u00fcber 3. Generations-Cephalosporinen (z. B. ESBL- E. coli)"},{"field":"Antimikrobiell-resistente Organismen","value":"Methicillin-resistente Staphylococcus aureus (MRSA)"},{"field":"Datenquelle","value":"Weltgesundheitsorganisation (WHO)"}],"computation_units":"Prozent","copyright":"&copy; Statistisches Bundesamt (Destatis), 2021","data_footnote":"Patienten, die eine Behandlung suchen und deren Blutprobe entnommen und getestet wird.","graph_title":"Anteil der Blutvergiftungen, die von bestimmten gegen antimikrobielle Wirkstoffe resistenten Organismen verursacht werden","graph_type":"line","show_line":true,"span_gaps":true,"precision":[{"decimals":2}],"previous":"3-d-1","next":"4-1-1","national_geographical_coverage":null,"page_content":"\n<span></span>","en":{"language":"en","national_indicator_available":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","comparison_sdg":null,"goal_meta_national_link_text":"Metadata on the presented time series","indicator_name":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","target_name":"Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks","un_designated_tier":"<a href=\"https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/\" title=\"Click here for more information on the UN tier classification.\"  target=\"_blank\">Tier II</a>","un_custodian_agency":null,"goal_meta_link_text":"Metadata on this indicator","goal_meta_2_link_text":null,"goal_meta_3_link_text":null,"source_organisation_1":"Robert Koch Institute","source_organisation_logo_1":"<a href=\"https://www.rki.de/EN/Home/homepage_node.html\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgEn/rki.png\" alt=\"Logo rki\" style=\"height:60px; width:148px\" /></a>","source_url_1":"https://apps.who.int/gho/tableau-public/tpc-frame.jsp?id=2012","source_url_text_1":"WHO - GLASS Country, territory and area profiles, 2018","source_url_text_1b":"Data from the ECDC Surveillance Atlas - Antimicrobial resistance","computation_units":"Percentage","copyright":"&copy; Federal Statistical Office (Destatis), 2021","data_footnote":"Patients seeking care and whose blood sample is taken and tested.","graph_title":"Percentage of bloodstream infections due to selected antimicrobial-resistant organisms","national_geographical_coverage":null,"page_content":"\n<span></span>"},"national_metadata_updated_date":"2021-07-02","national_data_updated_date":"2021-05-03","national_metadata_update_url_text":"2021-07-02: see changes on GitHub","national_metadata_update_url":"https://github.com/G205SDGs/sdg-data/commit/6a415365b7356cffd44a7d0bbd9465e20ed45390","national_data_update_url_text":"2021-05-03: see changes on GitHub","national_data_update_url":"https://github.com/G205SDGs/sdg-data/commit/a15d4e275c7c70898fb14e415f2e71cb4aae2e90","indicator":"3.d.2"}